Prova Ltd

Prova is a CRO supporting over 40 biotechnology and multinational companies. We offer analytical chemistry, biologicals analysis, pharmaceutical development and regulatory services. We now have over 200 ICH stability studies ongoing for new chemical entities and new biological entities in a variety of dosage forms and as the API.

Activity:

- Contract Research
- Licensing & Business Development
- Regulatory Affairs & Legal Services
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Drug delivery
- Enzymes
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive
- Proteins
- Technology

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Orthopedics
- Pain
- Pediatrics
- Radiology
- Reproductive Health
- Respiratory Medicine
- Stroke
- Surgery
- Tonics
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active: Europe , North America , Australia/New-Zealand

c. Countries active: United Kingdom, US, Germany, NZ, Australia

Corporate data:

Number of Employees: 44

Turnover:

Amount:	Year:	Currency:
2,580,000	2002	Euro

Year founded: 1990